Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)

SHA:600165 Revenue

In the year 2025, Ningxia Zhongke Biotechnology had annual revenue of 444.48M CNY with 28.72% growth. Ningxia Zhongke Biotechnology had revenue of 117.13M in the quarter ending December 31, 2025, a decrease of -27.15%.

• Revenue: 444.48M
• Revenue Growth: +28.72%
• P/S Ratio: 12.58
• Revenue / Employee: 532.95K
• Employees: 834
• Market Cap: 5.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	444.48M	99.16M	28.72%
Dec 31, 2024	345.32M	59.63M	20.87%
Dec 31, 2023	285.69M	-395.44M	-58.06%
Dec 31, 2022	681.13M	432.42M	173.86%
Dec 31, 2021	248.72M	129.60M	108.80%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 29, 2026

Data Sources Report a data error